Inhibition of the initiation stage of carcinogenesis by Salvia disermas constituents

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 64, Issue 11-12, 2010, Pages 831-839

  Hawas, Usama W ^a   Gamal Eldeen, Amira M ^a   El Toumy, Sayed A A ^a   Marion Meyer, J J ^b   Hussein, Ahmed A ^a,b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Flavonoids; Salvia disermas; Tumour anti initiating

Indexed keywords

SALVIA; SALVIA DISERMAS;

EID: 74049102338     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2009-11-1213     Document Type: Article

References (32)

1. Aggarwal B. B. and Shishodia S. (2006), Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 71, 1397-1421.
2. Akihisa T., Kimura Y., Koike K., Shibata T., Yoshida Z., Nikaido T., and Tamura T. (1998), Isohelianol: A 3,4-seco-triterpene alcohol from Sasanqua oil. J. Nat. Prod. 61, 409-412.
3. Autrup H. (1990), Carcinogen metabolism in cultured human tissues ans cells. Carcinogenesis 11, 707-712.
4. Bertram J. S. (2000), The molecular biology of cancer. Mol. Aspects Med. 21, 167-223.
5. Cannady E. A., Dyer C. A., Christian P. J., Sipes G., and Hoyer P. B. (2002), Expression and activity of microsomal epoxide hydrolase in follicles isolated from mouse ovaries. Tox. Sci. 68, 24-31.
6. Cao G. and Prior R. L. (1999), Measurement of oxygen radical absorbance capacity in biological samples. Methods Enzymol. 299, 50-62.
7. Crespi C. L., Miller V. P., and Penman B. W. (1997), Microtiter plate assays for inhibition of human, drugmetabolizing cytochromes P450. Anal. Biochem. 248, 188-190.
8. Dusut N., Ozden S., Umur E., Durust Y., and Kucukislamoglu M. (2001), The isolation of carboxylic acids from the flowers of Delphinium formosum. Turk. J. Chem. 25, 93-97.
9. Gamal-Eldeen A., Kawashty S., Ibrahim L., Shabana M., and El-Negoumy S. (2004), Evaluation of antioxidant, anti-inflammatory, and antinociceptive properties of aerial parts of Vicia sativa and its flavonoids. J. Nat. Remedies 4, 81-96.
10. Gerhäuser C., Klimo K., Heiss E., Neumann I., GamalEldeen A., Knauft J., Liu J.-U., Sitthimonchai S., and Frank N. (2003), Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutat. Res. 523-524, 163-172.
11. Griffith O. W. (1981), Determination of glutathione and glutathione disulphide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106, 207-212.
12. Habig W. H., Pabst M. J., and Jakoby W. B. (1974), Glutathione S-transferases.The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249, 7130-7139.
13. Hong W. K. and Sporn M. B. (1997), Recent advances in chemoprevention of cancer. Science 278, 1073-1077.
14. Inoue N., Yamada K., Imai K., and Aimoto T. (1993), Sex hormone-related control of hepatic EH activities in mice. Biol. Pharm. Bull. 16, 1004-1007.
15. Kamatou G. P. P., Van Zyl R. L., Van Vuuren S. F., Viljoen A. M., Figueiredo A. C., Pedro L. G., Barroso J. G., and Tilney P. M. (2006a), Chemical composition, leaf trichome types and biological activities of the essential oils of four related Salvia species indigenous to southern Africa. J. Essent. Oil Res. 18, 72-79.
16. Kamatou G. P. P., Van Zyl R. L., Van Vuuren S. F., Viljoen A. M., Figueiredo A. C., Pedro S. F., and Barroso L. G. (2006b), Biological activities and composition of Salvia muirii L. Bol. essential oil. J. Essent. Oil Res. 18, 48-51.
17. Kamatou G. P. P., Viljoen A. M., Van Vuuren S. F., and Van Zyl R. L. (2006c), In vitro evidence of antimicrobial synergy between Salvia chamelaeagnea and Leonotis leonurus. South Afr. J. Bot. 72, 634-637.
18. Mabry T. J., Markham K. R., and Thomas M. B. (1970), The Systematic Identification of Flavonoids. Springer-Verlag, Berlin.
19. McKelvey-Martin V. J., Melia N., Walsh I. K., Johnston S. R., Hughes C. M., Lewis S. E., and Thompson W. (1997), Two potential clinical applications of the alkaline single-cell gel electrophoresis assay: (1). Human bladder washings and transitional cell carcinoma of the bladder; and (2). human sperm and male infertility. Mutat. Res. 375, 93-104.
20. Mizuo M., Masaya K., Munekazu I., Toshiyuki T., Arika K., and Hiroyoshi O. (1987), Acylated luteolin glucosides from Salix gilgiana. Phytochemistry 26, 2418-4220.
21. Pervaiz S. (2003), Resveratrol: from grapevines to mammalian biology. FASEB J. 17, 1975-1985.
22. Petersen M. and Simmonds M. S. J. (2003), Rosmarinic acid. Phytochemistry 62, 121-125.
23. Rooseboom M., Commandeur J. N. M., and Vermeulen N. P. E. (2004), Enzyme-catalyzed activation of anticancer prodrugs. Pharmacol. Rev. 56, 53-102.
24. Shindo K., Saito E., Sekiya M., Matsui M., and Koike Y. (2008), Antioxidative activity of the flower of Torenia fournieri. Nat. Med. (Tokyo) 62, 247-248.
25. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., and Klenk D. C. (1985), Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85.
26. Sun S. Y., Hail N. Jr., and Lotan R. (2004), Apoptosis as a novel target for cancer chemoprevention. Natl. Cancer Inst. 96, 662-672.
27. Talapatra S. K., Bhar D. S., and Talapatra B. (1974), Antimycobacterial activity and cytotoxicity of flavonoids from the flowers of Chromolaena odorata. Phytochemistry 13, 284-285.
28. Thomas W. (2007), Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass. Semin. Cancer Biol. 17, 354-362.
29. Tice R. R., Agurell E., Anderson D., Benlinson B., Hartmann A., Kobayashi H., Miyamane Y., Rojas E., Ryu J. C., and Sasaki Y. F. (2000), Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 3, 206-211.
30. Tsao A. S., Kim E. S., and Hong W. K. (2004), Chemoprevention of cancer. CA Cancer J. Clin. 54, 150-180.
31. Williamson G., Plumb G. W., Uda Y., Price K. R., and Rhodes M. J. C. (1996), Dietary quercetin glycosides: antioxidant activity and induction of the anticarcinogenic phase II marker enzyme quinine reductase in Hep1c1c7 cells. Carcinogenesis 17, 2385-2387.
32. Yu R., Mandlekar S., Lei W., Fahl W. E., Tan T.-H., and Kong A. T. (2000), p38 Mitogen-activated protein kinase negatively regulates the induction of phase II drug-metabolizing enzymes that detoxify carcinogens. J. Biol. Chem. 275, 2322-2327.